Hims & Hers Health Stock: A Millionaire-Maker in the Making?
The stock has sprinted past $50 per share, after trading at $3 less than two years ago.
Shares of direct-to-consumer telehealth platform Hims & Hers Health (NYSE: HIMS) have become a runaway freight train. The stock has returned nearly 20-fold returns from its 2022 lows, including a blistering 490% over the past year alone. Those who got in early may have already made life-changing money on this stock.
Its momentum is no fluke. The company has continually touted robust growth, driven by a subscriber base that reached 2 million people in the third quarter of 2024. Those just now getting to know Hims & Hers might wonder whether this is a potential millionaire-maker in the making, or if the stock's about to run out of steam.
Here's what you need to know.
